CIK 0001521036 · Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352318913
- Phone
- 978 671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-12 | Ber Gerard Director | Sale 10b5-1 | −100 | $97.78 | $10K | 21,221 |
| 2024-08-08 | Blanchfield Paul President | Sale 10b5-1 | −2,000 | $96.39 | $193K | 98,980 |
| 2024-08-02 | Heino Mary Anne Director | Sale 10b5-1 | −6,724 | $95.20 | $640K | 458,680 |
| 2024-08-02 | Heino Mary Anne Director | Sale 10b5-1 | −3,661 | $96.01 | $351K | 455,019 |
| 2024-08-02 | Heino Mary Anne Director | Sale 10b5-1 | −96 | $96.68 | $9K | 454,923 |
| 2024-07-16 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −1,796 | $124.96 | $224K | 60,420 |
| 2024-07-15 | Blanchfield Paul President | Shares withheld for taxes | −518 | $123.19 | $64K | 100,980 |
| 2024-07-15 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $123.15 | $42K | 62,216 |
| 2024-07-10 | Pruden Gary J Director | Sale 10b5-1 | −12,530 | $95.04 | $1.2M | 11,978 |
| 2024-06-17 | Humphrey Jeffrey Chief Medical Officer | Grant or award | +9,076 | $82.63 | $750K | 9,076 |
| 2024-06-17 | Humphrey Jeffrey Chief Medical Officer | Grant or award · Stock Option (right to buy) | +16,188 | 16,188 | ||
| 2024-06-13 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $79.77 | $27K | 62,557 |
| 2024-06-07 | Heino Mary Anne Director | Sale | −1 | $81.26 | $81 | 37,719 |
| 2024-05-31 | Blanchfield Paul President | Sale 10b5-1 | −1,179 | $80.82 | $95K | 101,498 |
| 2024-05-30 | Niedzwiecki Daniel See Remarks | Sale 10b5-1 | −12,873 | $79.86 | $1.0M | 80,244 |
| 2024-05-28 | Maeusli Heinz Christoph Director | Option exercise 10b5-1 | +17,481 | $16.17 | $283K | 49,032 |
| 2024-05-28 | Maeusli Heinz Christoph Director | Sale 10b5-1 | −7.33 | $77.71 | $569 | 41,706 |
| 2024-05-28 | Maeusli Heinz Christoph Director | Sale 10b5-1 | −12,307 | $78.95 | $972K | 29,399 |
| 2024-05-28 | Maeusli Heinz Christoph Director | Sale 10b5-1 | −5,959 | $79.67 | $475K | 23,440 |
| 2024-05-28 | Maeusli Heinz Christoph Director | Sale 10b5-1 | −100 | $80.29 | $8K | 23,340 |
Page 8 of 9 · 177 trades